Generali Investments CEE’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.01M Hold
2,600
0.05% 289
2026
Q1
$761K Hold
2,600
0.04% 313
2025
Q4
$911K Hold
2,600
0.06% 257
2025
Q3
$840K Hold
2,600
0.06% 256
2025
Q2
$1.01M Hold
2,600
0.08% 228
2025
Q1
$1.13M Hold
2,600
0.11% 212
2024
Q4
$959K Buy
+2,600
New +$1.09M 0.1% 206

Other funds holding ELV

Generali Investments CEE's ELV Position: Q2 2026 in Review

Generali Investments CEE held its Elevance Health (ELV) position steady in Q2 2026 at 2,600 shares worth $1.01M. The position accounts for 0.05% of the portfolio, ranked #289.

Generali Investments CEE first reported a position in ELV in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.13M in Q1 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Generali Investments CEE held 2,600 shares of Elevance Health worth $1.01M as of Q2 2026.
  • Generali Investments CEE left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up 0.05% of Generali Investments CEE's portfolio in Q2 2026, its #289 holding.
  • Generali Investments CEE first reported a position in Elevance Health in Q4 2024 and has held it in 7 quarters since.
  • Generali Investments CEE's Elevance Health position peaked at $1.13M in Q1 2025.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Generali Investments CEE's 13F filing for Q2 2026, filed 13 Jul 2026.